All posts by: Michael Zand

About Michael Zand

Cell and Gene Therapy Catapult forges stronger link with Japan – PharmaTimes

Continue reading

2018-03-01 NEWS

PharmaTimes

Cell and Gene Therapy Catapult forges stronger link with Japan
PharmaTimes
The UK’s Cell and Gene Therapy Catapult (CGT Catapult) is linking with the Japanese Society for Regenerative Medicine (JSRM) to propel progress in regenerative medicine and cell/gene therapies in both countries. The parties have sighed a Memorandum of

Continue reading

2018-03-01 NEWS

Sacramento Bee

Will California’s $3 billion in stem cell spending pay off? First royalty check arrives
Sacramento Bee
Munos noted that times have changed since CIRM’s creation, which came during a period when former President George W. Bush had restricted government funding for research on embryonic stem cells. In that climate, California opted to step in with its own

Continue reading

2018-02-28 NEWS

As Cancer Immunotherapy Evolves, Challenges Compound for Diagnostic Development
GenomeWeb
NEW YORK (GenomeWeb) – At various sessions during Cambridge Healthtech Institute’s Molecular Medicine Tri-Conference earlier this month, representatives from the diagnostics arena, pharmaceutical companies, and the medical oncology field discussed the